1/6
08:17 am
prok
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/6
07:30 am
prok
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/27
08:02 am
prok
ProKidney Corp. (PROK) Positioned to Redefine Chronic Kidney Disease Treatment, Believes H.C. Wainwright [Yahoo! Finance]
High
Report
ProKidney Corp. (PROK) Positioned to Redefine Chronic Kidney Disease Treatment, Believes H.C. Wainwright [Yahoo! Finance]
12/17
07:26 am
prok
ProKidney (NASDAQ:PROK) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Medium
Report
ProKidney (NASDAQ:PROK) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
12/16
07:19 am
prok
ProKidney (NASDAQ:PROK) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Medium
Report
ProKidney (NASDAQ:PROK) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
11/10
05:06 pm
prok
ProKidney GAAP EPS of -$0.12 beats by $0.02, revenue of $0.22M beats by $0.18M [Seeking Alpha]
Low
Report
ProKidney GAAP EPS of -$0.12 beats by $0.02, revenue of $0.22M beats by $0.18M [Seeking Alpha]
11/10
04:41 pm
prok
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates [Yahoo! Finance]
Low
Report
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates [Yahoo! Finance]
11/10
04:15 pm
prok
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
Low
Report
ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates
11/6
11:00 am
prok
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
Medium
Report
ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025
10/29
07:30 am
prok
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference
Low
Report
ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference